NHS Framework Agreement, Branded Medicines for London and South of England

Concepts

• south of england
• runcorn
• pharmaceutical products
• nhs framework agreement
• nhs
• nhs framework
• north of england regions
• period of framework
• bevacizumab period of framework
• medicines

Location

Description

NHS Framework Agreement, Branded Medicines for London and South of England Offer reference number: CM/PHR/20/5598 FIND A TENDER (FTS) Reference number: FTS-002229 CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B. Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A. Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche. Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions - Bevacizumab Period of Framework: 1 September 2021 to 28 February 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months

Award Detail

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

Parties Awarded to Framework https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj4/e4859nDqBoS... 03. Framework Agreement and Terms and Conditions -CM_PHR_20_5598 NHS Framework Agreement, Branded Medicines for London and South of England Template https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVio/gHNH8g8.YgK... CM_PHR_20_5598_01 - NHS Framework LONDON Branded Medicines - Tranche B Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj3/F2uf5OXU_ZC... CM_PHR_20_5598_06 - NHS Framework Midlands & East and NofE - Bevacizumab Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVit/WA7wOa57AKO... CM _PHR_20_5598_03 - NHS Framework SOUTH of England Tranche A Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj2/no32CQoP7LD... CM_PHR_20_5598_04- NHS Framework SOUTH of England - Tranche B. Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVis/kL0N6R5Ggfo... CM_PHR_20_5598_02 - NHS Framework LONDON Branded Medicines - Annual Tranche Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVix/_0ogC52eXQS... CM_PHR_20_5598_05 - NHS Framework SOUTH of England Annual Tranche Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVin/epK1hXNyTh5...